Figure 3
From: A novel anti-IL4Rα nanoparticle efficiently controls lung inflammation during asthma
Effects of the anti-IL4Rα-NPs on the BALF inflammatory cells and IgE levels in the treated mice. (a) A significant decrease was observed in the frequency of BALF lymphocytes following treatment with anti-IL4Rα-NPs, as determined by fluorescence-activated cell sorting (FACS) analysis. (b) Serum and BALF IgE levels in the control and anti-IL4Rα-NP-treated mice. (*) for control vs OVA, **P<0.01, ***P<0.001; (#) for OVA vs anti-IL4Rα-NPs, #P<0.05, ##P<0.01, ###P<0.001.
